Deal will advance precision immuno-oncology candidates from Marengo’s STAR platform
News
Cyclerion reveals data for schizophrenia therapy
Study data demonstrates positive effects of CY6463 on cognition and inflammation
Tallac announces first patient treated with TAC-001
The phase 1/2 study is for patients with advanced or metastatic solid tumours
CNX embarks on buy-and-build strategy
Investment is a key boost to the acceleration of treatment access in the UK
Scientists to rewrite DNA in search for heart disease cure
The British Heart Foundation’s ‘Big Beat Challenge’ grant of £30m for research into cardiovascular medicine was given to CureHeart
Novartis’ Beovu recommended by NICE
Patients set to benefit from new treatment for sight-threatening eye condition
Roche testing to help diagnose pre-eclampsia receives NICE recommendation
Predicting which women are likely to develop pre-eclampsia will help clinicians to decide on the most appropriate care
Chiesi reinforces commitment to reducing emissions
First carbon minimal pMDI is on track with the joint goal of benefitting patients and the planet
Iconovo receives $883,800 grant from the Bill & Melinda Gates Foundation
Funding will develop inhaled therapies using ICOone Nasal in preparation for the next pandemic
MHRA grants marketing authorisation for Global Blood Therapeutics’s Oxbryta
Voxelotor is the first medicine in Britain to directly inhibit sickle haemoglobin polymerisation
Aurinia receives positive CHMP opinion for Lupkynis
Therapy effectively treats adults with active lupus nephritis in Europe
Bavarian Nordic receives European approval of vaccine label Imvanex
Imvanex to include protection from monkeypox and diseases caused by vaccinia virus
NICE recommends Rhythm’s Imcivree to help treat obesity and control hunger
The treatment has been developed for people aged six years and over will be available for use across the NHS
Vicebio targets development of novel vaccines
Molecular clamp technology is a protein tag that stabilises a wide range of complex viral proteins
NHS leaders facing real-terms reduction in funding
Difficult choices loom regarding which areas of patient care to cut back
